2-bromo-N-methyl-N-(4-nitrophenyl)acetamide

We are 2-bromo-N-methyl-N-(4-nitrophenyl)acetamide CAS:23543-31-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:   2-bromo-N-methyl-N-(4-nitrophenyl)acetamide
CAS.NO: 23543-31-9
Synonyms:
N-bromoacetyl-N-methyl-4-nitro-aniline
N-(2-bromomethylcarbonyl)-N-methyl-4-nitroaniline
2-Brom-4'-nitro-N-methylacetanilid
N-methyl-4-nitro-

Molecular Formula: C9H9BrN2O3
Molecular Weight:  273.08300

Physical and Chemical Properties:
Density: 1.6g/cm3
Boiling point: 387.2 °C at 760 mmHg
Melting point: /
Flash point:188.0°C
Refractive index: 1.636

Specification:
Appearance: white solid
Purity:≥99%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage: Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:
Intermediates of Nintedanib esylate CAS:656247-18-6
Intermediates of Nintedanib CAS:656247-17-5

Related News: ICIG has agreed to offer employment to the unit’s approximately 120 employees upon closing, and plans to maintain operations at its primary location, a manufacturing facility in Liestal, Switzerland.6-bromo-2-chloro-3-fluoropyridine CAS:1211591-93-3 At the same time, experts said that API companies need to increase investment in environmental protection, carry out industrial upgrades, improve processes, improve pollution treatment capabilities, and then achieve sustainable development in the future, and seize structural opportunities.N-[3-(methylamino)propyl]oxolane-2-carboxamide Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.2-Allyl-4-hydroxy-3-methyl-2-cyclopenten-1-one CAS:29605-88-7 The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.Among the APIs we produce, there is an API which passes through over ten kinds of intermediates in a process when it changes from being a raw material into an API.